Guidance in topic selection

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Technology type

Technology type

Topic selection decision

Topic selection decision

Type 1 selected

Type

Showing 1 to 10 of 13

TitleTechnology typeDecisionDecision date
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years TS ID 12092MedicineNot selected
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 5 to 11 TS ID 11806MedicineNot selected
Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years TSID 12002MedicineNot selected
Ivacaftor for treating cystic fibrosis with mutations in the CFTR gene in babies and children aged 1 to 3 months or weighing 3 kg to 24 kg TS ID 11894MedicineNot selected
Spineform Hemibridge endoscopic vertebral stapling to reduce curvature in the growing scoliotic spine in childrenProcedureNot selected
Elexacaftor–tezacaftor–ivacaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in children aged 2 to 5 TS ID 10767MedicineNot selected
Baricitinib for treating moderate to severe atopic dermatitis in children and young people aged 2 to 17 [TS ID 10639]MedicineNot selected
Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 TS ID 11828MedicineNot selected
Dulaglutide for treating type 2 diabetes in children and young people TS ID 10660MedicineNot selected
Dupilumab for children with severe atopic dermatitis [TS ID 10434]MedicineNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All